ZOLL LIFEVEST SELECTED AS ONE OF THE TOP FIVE INNOVATIVE
MEDICAL DEVICES OF 2009 BY THE MEDICAL DEVICE NETWORKINVESTOR
CONTACT: Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655
MEDIA CONTACT: Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
FOR IMMEDIATE RELEASE
January 28, 2010—CHELMSFORD, MASS.--ZOLL Medical Corporation (Nasdaq GS:
ZOLL), a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.
Reporter Frances Penwill-Cook of the U.K.-based Medical Device Network explained, “The LifeVest was selected because we felt it was technologically exceptional, that it would
experience widespread use due to excellent functionality and that it would have a significant impact on patient care.”
“To receive this designation from a large and respected internet reference portal indicates that the LifeVest is gaining visibility on the international front as a standard of care,” said Richard A. Packer, Chairman and CEO of ZOLL. “The LifeVest Wearable Defibrillator has protected more than 21,000 patients at high risk of sudden cardiac arrest.”
The LifeVest Wearable Defibrillator is worn by patients at risk for sudden cardiac arrest (SCA), providing protection during their changing condition and while permanent SCA risk has not been established. The LifeVest allows a patient’s physician time to assess his or her long-term arrhythmic risk and make appropriate plans.
The LifeVest is lightweight and easy to wear, allowing patients to return to their activities of
daily living, while having the peace of mind that they are protected from SCA. The LifeVest
continuously monitors the patient’s heart and, if a life-threatening heart rhythm is detected, the device delivers a treatment shock to restore normal heart rhythm.
The LifeVest is used for a wide range of patient conditions or situations, including following a heart attack, before or after bypass surgery or stent placement, as well as for those with
cardiomyopathy or congestive heart failure that places them at particular risk.
About Medical Device Network
Medical Device Network is an online U.K.-based procurement and reference resource for
professionals and decision makers within the international medical device and diagnostics
industry. To read more about Medical Device Network’s special feature on 2009's Top Five Innovative Devices, please visit http://www.medicaldevice-network.com/features/feature73080/.
To learn more about the LifeVest, visit www.zoll.com/lifevest or call 1-800-543-3267.
About ZOLL Medical Corporation
ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational
efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.
A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company for the past three years, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe.
For more information, visit www.zoll.com.
Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K filed with the SEC on December 10, 2009. You should not place undue reliance on the forward looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.
Copyright © 2010 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL and LifeVest are
registered trademarks of ZOLL Medical Corporation.